FDA Drug Recalls

Recalls / Class I

Class ID-1057-2014

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), 250 mL glass containers, Baxter Healthcare Corp., Deerfield, IL --- NDC 0338-1049-02

Brand name
Nitroglycerin In Dextrose
Generic name
Nitroglycerin
Active ingredient
Nitroglycerin
Route
Intravenous
NDCs
0338-1047, 0338-1049, 0338-1051
FDA application
NDA019970
Affected lot / code info
G105197, Exp. 02/14

Why it was recalled

Presence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.

Recalling firm

Firm
Baxter Healthcare Corp.
Manufacturer
Baxter Healthcare Company
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Baxter Pkwy, Deerfield, Illinois 60015-4625

Distribution

Quantity
49,932 glass containers
Distribution pattern
Nationwide, Saudi Arabia and Colombia

Timeline

Recall initiated
2013-11-18
FDA classified
2014-01-31
Posted by FDA
2014-02-12
Terminated
2014-09-15
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1057-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class I recall: Nitroglycerin In Dextrose · FDA Drug Recalls